26Apr

Free Workshop – “FIT to Practice?” Alpha Laboratories at ACB FOCUS 2018

Faecal Immunochemical Testing (FIT) is now an established diagnostic test that identifies the presence of minute quantities of haemoglobin (blood) in the stool, known as faecal occult blood (FOB), which can be an early sign of colorectal cancer. FIT uses antibodies specific to human haemoglobin so is more sensitive and has a greater specificity than the previous qualitative guaiac based methods. 

NICE DG30 now recommends the use of FIT to guide referral for colorectal cancer in primary care. At ACB Focus Mr Nigel D’Souza will present preliminary data from the NICE FIT study launched through Croydon University Hospital and RM Partners Accountable Cancer Network. As one of the largest studies on FIT it aims to recruit 5,500 patients to evaluate the diagnostic accuracy of FIT particularly in diverse populations.

Come and find out more about the NICE FIT study at Alpha Laboratories’ workshop on Thursday 7th June (9:50-10:30), or come and talk to our team on stand #6. The workshop is chaired by Professor Callum Fraser and Sally Benton, director of the Bowel Cancer Screening Hub in Guildford will also be present.

Please visit www.faecal-immunochemical-test.co.uk for further information or contact Alpha Laboratories on
0800 38 77 32 or email marketing@alphalabs.co.uk

Related

DEMAND FOR GENETIC TESTING DRIVES GROWTH FOR AWARD WINNING ELUCIGENE DIAGNOSTICS

30 percent growth and innovation products wins Manchester company BVCA award. Having the right te...

Read More >

EKF Diagnostics opens new R&D facility in UK

Special Projects Laboratory opened in EKF’s Cardiff HQ to develop new applications in non-core ma...

Read More >

European Reference Laboratory for Glycohemoglobin study reaffirms EKF’s Quo-Test® meets HbA1c performance criteria

Cardiff, UK – 16th February 2017 – EKF Diagnostics, the global in vitro diagnostics company, annou...

Read More >

BBI Solutions broadens antibody portfolio and strengthens reagent technical support capabilities with acquisition of Maine Biotechnology Services

BBI Solutions (BBI) has announced the addition of over 80 new antibodies to its growing product port...

Read More >

Idris Oncology one of first companies to receive free human tissue through Codex4SME’s

The Leiden based biotechnology firm Idris Oncology is one of the three SME’s in Europe to receive h...

Read More >

Diabetes Research Unit Cymru confirms EKF POCT HbA1c testing comparable to lab-based HPLC

Cardiff, UK – 21st June 2017 – EKF Diagnostics, the global in vitro diagnostics company, announces...

Read More >